Bret Jensen
Contributor since: 2010
Company: The Biotech Forum
The Verdict On Actinium Pharmaceuticals
Our First Peek At Passage Bio
Circling Back On OncoCyte Stock
Our First Look At Fulcrum Therapeutics
Circling Back On NuCana Stock
Sizing Up Spectrum Pharmaceuticals
Circling Back On Axsome Therapeutics
Fathoming The FDA Decision On FibroGen
The Outlook For Athersys Stock
Dynavax Technologies: A Surprising COVID-19 Play
Celsion: Still Waiting For Godot
Supernus Pharmaceuticals: Solid Quarter, Solid Stock
Checking Back On Kadmon Holdings
CTI BioPharma: Potential Light At End Of The Rainbow
Going Under The Covers With Surface Oncology
Circling Back On Clearside Biomedical
Vectoring In On Viking Therapeutics
Wave Life Sciences: Hanging Around $10
Our First Look At Protara Therapeutics
CymaBay Therapeutics: Checking In On This Roller Coaster Stock
Revisiting Reata Pharmaceuticals Again
Revisiting Recro Pharma
The Latest On Xeris Pharmaceuticals
Reassessing Epizyme
The Verdict On Venus Concept
Zogenix: Our Current Take On This 'Battleground' Biopharma Stock
The Right Call On Cara Therapeutics
Heron Therapeutics: A Name That Could Gain Traction In 2021
Beyond Air: A Name To Keep An Eye On
Taking Another Gander At Greif
Revisiting Radius Health
Assessing Aurinia Pharmaceuticals Post FDA Approval